CD8a (Ly2, T cell Co-receptor, Leu2, T8) (FITC)

Cat# C2259-29P-500ug

Size : 500ug

Marca : US Biological



C2259-29P CD8a (Ly2, T cell Co-receptor, Leu2, T8) (FITC)

Clone Type
Monoclonal
Host
mouse
Source
porcine
Isotype
IgG2a,k
Grade
Purified
Applications
FC IP
Crossreactivity
Po
Shipping Temp
Blue Ice
Storage Temp
-20°C

Porcine CD8, a type I transmembrane glycoprotein, is expressed as either a CD8alpha/alpha homodimer or a CD8alpha/beta heterodimer. It is found on most thymocytes, and on the “suppressor/cytotoxic” subpopulation of peripheral T cells. CD8 functions primarily as a co-receptor with MHC Class I-restricted T-cell receptors in antigen recognition.

Applications:
• Flow cytometry1-3
• Immunoprecipitation1
• Cytotoxicity assays1,2

Recommended Dilution:
Flow Cytometry: ≤ 1ug/10e6 cells
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and add glycerol (40-50%). Store at -20°C or colder. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Applications
Product Type: Mab|Isotype: IgG2a,k|Clone No: 76-2-11|Host: mouse|Source: porcine|Concentration: ~0.5mg/ml|Form: Supplied as a liquid in PBS, 0.09% sodium azide. Labeled with FITC.|Purity: Purified|Specificity: Recognizes porcine CD8a, Mr 32-34kD. Reacts with the CD8 alpha chain.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in PBS, 0.09% sodium azide. Labeled with FITC.
Purity
Purified
Specificity
Recognizes porcine CD8a, Mr 32-34kD. Reacts with the CD8 alpha chain.
References
1. Pescovitz, M.D, .K. Lunney, and D.H. Sachs. 1984. J. Immunol. 133:368.|2. Yamada, K., D.H. Sachs, and H. DerSimonian. 1995. J. Immunol. 155:5249.|3. Smith, C.V., T. Sablinski, J.S. Arn, et al. 1994. J. Immunother. with Emphasis on Tumor Immunology 16:105.